4, 5-diaminofluorescein

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 4, 5-diaminofluorescein
• 英文别名: Diaminofluorescein；DAF；3',6'-Dihydroxy-4,5-diaminospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one；6,7-diamino-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one
• 化学式: C₂₀H₁₄N₂O₅
• 分子量: 362.342
• InChiKey: LPVRTLOUIWNQCQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  27
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  128
• 氢给体数：
  4
• 氢受体数：
  7

文献信息

• [EN] DUAL ACTION NITRIC OXIDE DONORS AND THEIR USE AS ANTIMICROBIAL AGENTS<br/>[FR] DONNEURS D'OXYDE NITRIQUE À DOUBLE ACTION ET LEUR UTILISATION COMME AGENTS ANTIMICROBIENS
  申请人：NEWSOUTH INNOVATIONS PTY LTD

  公开号：WO2014071457A1

  公开（公告）日：2014-05-15

  The present invention relates generally to conjugates comprising a nitric oxide donor and an acyl homoserine lactone, fimbrolide, fimbrolide derivative, dihydropyrrolone or indole, and to the use of such conjugates as antimicrobial agents.

  本发明涉及一般地与一氧化氮供体和酰基同源丁氨酸内酯、菲螺啉、菲螺啉衍生物、二氢吡咯酮或吲哚构成的结合物，以及将这些结合物用作抗微生物剂的用途。
• NITRIC OXIDE DONOR NEPRILYSIN INHIBITORS
  申请人：Mammen Mathai

  公开号：US20130323271A1

  公开（公告）日：2013-12-05

  In one aspect, the invention relates to compounds having the formula: where R 1 , R 2 , R 3 , R 7 , R 8 , Z, X, b, and c are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds are nitric oxide donors and have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.

  在一方面，本发明涉及具有以下公式的化合物：其中R1、R2、R3、R7、R8、Z、X、b和c按说明书定义，或其药用可接受的盐。这些化合物是氧化氮供体并具有中性内肽酶抑制活性。在另一方面，本发明涉及包含此类化合物的药物组合物；使用此类化合物的方法；以及制备此类化合物的过程和中间体。
• Coordination complexes for detecting analytes, and methods of making and using the same
  申请人：——

  公开号：US20030068275A1

  公开（公告）日：2003-04-10

  The present invention is directed, in part, to coordination complexes for detecting analytes, and methods of making and using the same.

  本发明部分涉及用于检测分析物的配位络合物，以及制备和使用该配位络合物的方法。
• [EN] ARYLPIPERAZINES AS NEUROPROTECTIVE AGENTS<br/>[FR] ARYLPIPÉRAZINES EN TANT QU'AGENTS NEUROPROTECTEURS
  申请人：PROTEOSYS AG

  公开号：WO2012127030A1

  公开（公告）日：2012-09-27

  The present invention generally relates to novel arylpiperazines. In particular, these arylpiperazines can be used as neuroprotective agents. The invention also relates to a process for the manufacture of the novel compounds. Further, the invention relates to the use of the novel arylpiperazines in the treatment of diseases associated with, accompanied by or caused by mitochondrial stress.

  本发明一般涉及新型芳基哌嗪。具体而言，这些芳基哌嗪可用作神经保护剂。本发明还涉及一种制造这些新型化合物的方法。此外，本发明还涉及将这些新型芳基哌嗪用于治疗与、伴随或由线粒体应激引起的疾病的用途。
• Bisaryl-sulfonamides
  申请人：Bergeron Philippe

  公开号：US20060084802A1

  公开（公告）日：2006-04-20

  Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ or PPARδ. In particular, the compounds of the invention modulate the function of PPARγ or PPARδ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.

  提供了在治疗或预防由PPARγ或PPARδ介导的疾病或紊乱方面有用的化合物、组合物和方法。具体来说，本发明的化合物调节PPARγ或PPARδ的功能。该方法特别适用于治疗和/或预防糖尿病、肥胖症、高胆固醇血症、类风湿性关节炎和动脉粥样硬化。